Feds Subpoena Boston Scientific Corporation, Seeks Information About 2012 Acquisition Of BridgePoint Medical

Boston Scientific (NYSE:BSX) informed investors this week that it's under investigation by the U.S. Attorney for the District of New Jersey over a cardiology devices company acquired 2 years ago.

Boston Scientific reported in its most recent quarterly report that it was served with a subpoena for information about its 2012 acquisition of BridgePoint Medical as well as sales and training activities for BridgePoint's CrossBoss CTO-crossing catheter and Stingray CTO re-entry system.

The subpoena was served on July 11, 2014, according to an SEC filing, and Boston Scientific said that it's cooperating with the authorities.

Help employers find you! Check out all the jobs and post your resume.